RxDoctor Payments Data

Paul Francis

Psychiatric/Mental Health · Prestonsburg, KYNPI 1154088482

Payments from drug & device makers

$4,646in general payments, 2019–2025

Across 283 payments — averaging $16.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$606
  • Vanda Pharmaceuticals Inc.$516
  • AbbVie$485
  • Alkermes, Inc.$435
  • Lundbeck LLC$393
  • Indivior Inc.$391
  • plus $2K from 12 others

What the payments were for

  • Food & beverage$4,58499%
  • Education$621%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,646 in reported general payments places this provider in the 90th percentile of 946 psychiatric/mental health providers in Kentucky.

See all psychiatric/mental health providers in Kentucky

Medicare billing

Part B allowed, 2024
$20,874
Medicare patients
45
Services billed
311

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate146$437,234
IngrezzaValbenazine Tosylate17$139,155
AustedoDeutetrabenazine14$103,052
LybalviOlanzapine/Samidorphan Malate35$54,107
Abilify MaintenaAripiprazole12$33,695
VraylarCariprazine Hcl19$27,189
VivitrolNaltrexone Microspheres15$23,427
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl408$19,340
RexultiBrexpiprazole11$18,553
TrintellixVortioxetine Hydrobromide21$14,698
Divalproex Sodium227$8,370
Paliperidone ErPaliperidone35$6,936
Clozapine92$5,616
Chlorpromazine Hcl18$5,414
SuboxoneBuprenorphine Hcl/Naloxone Hcl22$5,274

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$374$437,234146 claims
Neurocrine Biosciences, Inc.Ingrezza$215$139,15517 claims
Teva Pharmaceuticals USA, Inc.Austedo$390$103,05214 claims
Alkermes, Inc.Lybalvi, Vivitrol$435$77,53450 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti$390$52,24823 claims
AbbVieVraylar$485$27,18919 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$40$14,69821 claims
Indivior Inc.Suboxone$391$5,27422 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 946 psychiatric/mental health providers in Kentucky.

Other psychiatric/mental health in Prestonsburg

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →